Eastern Mediterranean (WHO region) vs Saudi Arabia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Eastern Mediterranean (WHO region)
61.0%
in 2025
Saudi Arabia
98.0%
in 2025
Eastern Mediterranean (WHO region) rank
9th
Saudi Arabia rank
11th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Eastern Mediterranean (WHO region)
- Saudi Arabia
How they compare
Saudi Arabia currently reports 98.0% against 61.0% in Eastern Mediterranean (WHO region), a difference of 37.0%.
That makes Saudi Arabia's figure about 1.6 times Eastern Mediterranean (WHO region)'s.
Across all 18 years both countries report, Saudi Arabia has been ahead every year.
Eastern Mediterranean (WHO region) ranks 9th and Saudi Arabia ranks 11th of 11 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 49.0% | 47.0% | Saudi Arabia |
| 2010s | 37.1% | 97.8% | 60.7% | Saudi Arabia |
| 2020s | 54.7% | 96.8% | 42.2% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Eastern Mediterranean (WHO region) or Saudi Arabia?
- Saudi Arabia, at 98.0% against 61.0% in Eastern Mediterranean (WHO region) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Eastern Mediterranean (WHO region) and Saudi Arabia?
- 37.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Saudi Arabia?
- 18 years are reported by both, from 2008 to 2025.
- How do Eastern Mediterranean (WHO region) and Saudi Arabia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Eastern Mediterranean (WHO region) ranks 9th and Saudi Arabia ranks 11th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.